Practical training designed for teams that want to make better decisions, not just receive better advice.
The most common source of translational failure is not bad science — it is the wrong scientific questions being asked at the wrong time. Teams that understand biomarker strategy ask better questions of their consultants, vendors, and clinical partners.
Our training is designed for scientists who are technically strong in their own discipline but want a more systematic understanding of how biomarker strategy and translational medicine shape programme success.
All sessions are grounded in real-world examples and directly applicable to your current projects — not abstract frameworks.
Half-day or full-day workshops, shorter sessions across a project, or an ongoing learning thread embedded within an active collaboration. In person, remote, or hybrid — all tailored to your stage, therapeutic area, and current portfolio.
What biomarkers are, what they are not, and how to build a fit-for-purpose programme from target selection to clinical read-out.
Designing a preclinical package that supports clinical decision-making — common pitfalls and how to avoid them.
Building the scientific rationale for patient stratification through to companion diagnostic strategy.
Reading clinical data critically and framing go/no-go decisions clearly for stakeholders.
Scientists moving compounds toward the clinic who want to understand what clinical development will demand of their data.
Programme leaders who want a deeper understanding of biomarker strategy, endpoint selection, and trial design.
Founders and scientific leaders making strategic decisions across the full drug development continuum.
Schedule a call to discuss your programme and explore what we can do together.
Book a free consultation